(Q42943425)

English

Pharmacodynamic effect of clinical vancomycin exposures on cell wall thickness in heterogeneous vancomycin-intermediate Staphylococcus aureus

scientific article published on August 6, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Pharmacodynamic effect of clinical vancomycin exposures on cell wall thickness in heterogeneous vancomycin-intermediate Staphylococcus aureus (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Warren E. Rose

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693174

18 June 2024

Ryan M. Knier

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693174

18 June 2024

Paul R. Hutson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693174

18 June 2024

language of work or name

0 references

publication date

6 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

full work available at URL

https://academic.oup.com/jac/article-pdf/65/10/2149/2084683/dkq292.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693174

18 June 2024

http://jac.oxfordjournals.org/cgi/content/abstract/65/10/2149

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693174

18 June 2024

http://academic.oup.com/jac/article-pdf/65/10/2149/2084683/dkq292.pdf

Portable Document Format

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

2149-2154

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007).

1

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center

2

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital

3

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus

4

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia

5

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia

6

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus

7

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

8

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

9

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?

10

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: implications for polysaccharide intercellular adhesin synthesis and autolysis

11

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains

12

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Impact of inoculum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in vitro pharmacodynamic model

13

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model

14

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital

15

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Detection of glycopeptide resistance in Staphylococcus aureus

16

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

High-performance liquid chromatographic determination of vancomycin in rabbit serum, vitreous and aqueous humour after intravitreal injection of the drug

17

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin

18

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Inhibition of the autolytic system by vancomycin causes mimicry of vancomycin-intermediate Staphylococcus aureus-type resistance, cell concentration dependence of the MIC, and antibiotic tolerance in vancomycin-susceptible S. aureus

19

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

20

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).

21

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus

22

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing

23

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients

24

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

25

1 reference

10.1093/JAC/DKQ292

https://api.crossref.org/works/10.1093/JAC/DKQ292

18 June 2024

Identifiers

10.1093/JAC/DKQ292

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42943425&oldid=2183029535"